Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Immunext Inc patents


Recent patent applications related to Immunext Inc. Immunext Inc is listed as an Agent/Assignee. Note: Immunext Inc may have other listings under different names/spellings. We're not affiliated with Immunext Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Immunext Inc-related inventors


Anti-cd154 antibody having improved binding, functional and safety characteristics and use in human immunotherapy

Improved anti-cd154 antibodies are provided herein which have improved therapeutic potency, in vivo half-life and ablated fcr binding and/or complement binding/activation. The use of these antibodies for inducing tolerance and treating immune diseases including autoimmunity, inflammation, transplant recipients, fibrosis and allergic disorders is disclosed herein.. ... Immunext Inc

Anti-human vista antibodies and use thereof

The invention provides agonistic anti-human vista antibodies and antibody fragments. These agonist antibodies and antibody fragments may be used to potentiate or enhance or mimic vista's suppressive effects on t cell immunity and thereby suppress t cell immunity. ... Immunext Inc

Anti-human vista antibodies and use thereof

The invention provides agonistic anti-human vista antibodies and antibody fragments. These agonist antibodies and antibody fragments may be used to potentiate or enhance or mimic vista's suppressive effects on t cell immunity and thereby suppress t cell immunity. ... Immunext Inc

Anti-human vista antibodies and use thereof

The invention provides agonistic anti-human vista antibodies and antibody fragments. These agonist antibodies and antibody fragments may be used to potentiate or enhance or mimic vista's suppressive effects on t cell immunity and thereby suppress t cell immunity. ... Immunext Inc

Anti-human vista antibodies and use thereof

The invention provides agonistic anti-human vista antibodies and antibody fragments. These agonist antibodies and antibody fragments may be used to potentiate or enhance or mimic vista's suppressive effects on t cell immunity and thereby suppress t cell immunity. ... Immunext Inc

Use of vista agonists and antagonists to suppress or enhance humoral immunity

The present invention is directed to the use of vista agonists alone or in association with other immune inhibitors, preferably another inhibitor of humoral immunity such as an inos/no promoter or nitric oxide or a pd-1 or pd-l1 agonist or a cd40 antagonist for the treatment or prevention of conditions wherein the suppression of humoral immunity is therapeutically beneficial. The present invention is further directed to the use of vista antagonists alone or in association with other immune agonists, preferably another enhancer of humoral immunity such as inos/no inhibitor or a pd-1 or pd-l1 antagonist or anti-ctla-4 antibody or a cd40 agonist for the treatment or prevention of conditions wherein the enhancement of humoral immunity is therapeutically beneficial. ... Immunext Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Immunext Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Immunext Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###